Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies (Details Narrative)

v3.20.1
Description of Business and Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 06, 2018
shares
Mar. 30, 2020
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Segments
shares
Dec. 31, 2018
USD ($)
Oct. 31, 2019
USD ($)
Jan. 02, 2019
USD ($)
Number of offering shares of common stock | shares       12,011,269      
Net loss     $ (1,613,972) $ (5,787,364)      
Net cash used in operating activities     (1,028,501) (2,221,320)      
Working capital deficiency       113,909      
Cash on hand     35,820 433,143 $ 35,820    
Proceeds from issuance of convertible note payable     326,800      
Allowance of uncollectible accounts        
Inventory reserve        
Estimated useful lives of equipment       3 years      
Impairment of property plant and equipment          
Operating lease right-of-use assets     332,980    
Operating lease liabilities     85,662    
Advertising costs     27,529 103,401      
Research and development costs     $ 207,600 351,670      
Derivative liability fair value       $ 400,139   $ 565,195  
Operating segments | Segments       1      
Accounts Receivable [Member] | Customer One [Member]              
Concentration risk percentage       19.00%      
Accounts Receivable [Member] | Customer Two [Member]              
Concentration risk percentage       12.00%      
Accounts Receivable [Member] | No Other Customer [Member]              
Concentration risk percentage       10.00% 10.00%    
No Customer [Member] | Revenue Benchmark [Member]              
Concentration risk percentage     10.00% 10.00%      
No Vendor [Member] | Accounts Payable [Member]              
Concentration risk percentage       10.00%      
Convertible Notes Payable [Member]              
Potentially dilutive shares outstanding | shares       889,469      
Restricted Stock [Member]              
Potentially dilutive shares outstanding | shares       8,000,000      
Stock Options [Member]              
Potentially dilutive shares outstanding | shares       3,290,000      
Warrants [Member]              
Potentially dilutive shares outstanding | shares       3,000,000      
ASC 842 [Member]              
Operating lease right-of-use assets             $ 420,112
Operating lease liabilities             $ 420,112
Subsequent Event [Member]              
Proceeds from issuance of convertible note payable   $ 153,000          
Subscription for shares of common stock received   $ 30,000          
Freight Solution [Member]              
Shares issued and outstanding percentage 23.00%            
Bioanomaly, Inc. [Member]              
Business acquisition number of shares issued | shares 21,908,810            
Number of offering shares of common stock | shares 6,500,000